Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0180
0.00 (0.00%)
Sep 18, 2026, 4:10 PM AEST
Atomo Diagnostics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 5.33 | 3.79 | 4.09 | 2.54 | 12.34 | |
Revenue Growth | 40.65% | -7.20% | 60.65% | -79.38% | 83.69% |
Cost of Revenue | 3.57 | 2 | 2.65 | 3.05 | 8.45 |
Gross Profit | 1.76 | 1.79 | 1.44 | -0.5 | 3.88 |
Selling, General & Admin | 3.83 | 4.72 | 5.3 | 6.57 | 7.3 |
Research & Development | 0.76 | 0.62 | 0.24 | 0.6 | 1.41 |
Other Operating Expenses | 0.77 | 0.7 | 0.75 | 1.16 | -1.73 |
Operating Expenses | 6.79 | 7.63 | 7.94 | 10.23 | 8.98 |
Operating Income | -5.02 | -5.84 | -6.51 | -10.73 | -5.1 |
Interest Expense | -0.01 | -0.02 | -0.01 | -0.01 | -0.02 |
Interest & Investment Income | 0.08 | 0.06 | 0.15 | 0.07 | 0.01 |
Currency Exchange Gain (Loss) | -0.04 | -0.01 | 0.03 | 0.11 | 0.09 |
Other Non Operating Income (Expenses) | 1.49 | 0.83 | 0.29 | 0.6 | -0.69 |
EBT Excluding Unusual Items | -3.51 | -4.97 | -6.05 | -9.96 | -5.71 |
Asset Writedown | - | - | -0.8 | - | - |
Pretax Income | -3.51 | -4.97 | -6.85 | -9.96 | -5.71 |
Net Income | -3.51 | -4.97 | -6.85 | -9.96 | -5.71 |
Net Income to Common | -3.51 | -4.97 | -6.85 | -9.96 | -5.71 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 827 | 647 | 635 | 571 | 569 |
Shares Outstanding (Diluted) | 827 | 647 | 635 | 571 | 569 |
Shares Change | 27.85% | 1.96% | 11.17% | 0.34% | 0.82% |
EPS (Basic) | -0.00 | -0.01 | -0.01 | -0.02 | -0.01 |
EPS (Diluted) | -0.00 | -0.01 | -0.01 | -0.02 | -0.01 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -3.4 | -1.99 | -4.7 | -5.91 | -4.2 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 |
Gross Margin | 33.05% | 47.28% | 35.16% | -19.71% | 31.47% |
Operating Margin | -94.19% | -153.90% | -159.22% | -421.68% | -41.30% |
Profit Margin | -65.87% | -131.08% | -167.57% | -391.46% | -46.26% |
Free Cash Flow Margin | -63.80% | -52.54% | -115.06% | -232.25% | -34.04% |
EBITDA | -4.09 | -4.69 | -5.27 | -9.25 | -3.63 |
EBITDA Margin | -76.64% | -123.79% | -129.00% | - | -29.45% |
D&A For EBITDA | 0.94 | 1.14 | 1.24 | 1.48 | 1.46 |
EBIT | -5.02 | -5.84 | -6.51 | -10.73 | -5.1 |
EBIT Margin | -94.19% | -153.90% | -159.22% | - | -41.30% |